Filed: 8/14/2026ACC: 0001104659-26-096822
📋 What this filing means
ACUTA CAPITAL PARTNERS, LLC filed this quarterly 13F‑HR report disclosing 23 equity positions with a total reported market value of $143.49M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
23
Positions
$143.49M
Total AUM (reported)
10.41M
Total Shares
Allocation by class
COM$79.24M55.2%
COM NEW$46.11M32.1%
COM SHS$8.55M6.0%
SPONSORED ADR$4.37M3.0%
CLASS ORD A$4.20M2.9%
CL A$1.03M0.7%
Portfolio Concentration
Top 3$61.40M42.8%
4–10$44.42M31.0%
11–25$37.67M26.3%
Top 3 weight
42.8%
Top 10 weight
73.7%
Voting Authority Distribution
Total shares with voting rights: 10.41M
Sole
Full voting authority
10.41M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole23
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings23
Rows:
PRAXIS PRECISION MEDICINES I
SOLEShares82.80K
TypeSH
Market value$27.72M
19.32%
Sole
82.80K
Shared
0.00
None
0.00
WHITEHAWK THERAPEUTICS INC
SOLEShares4.69M
TypeSH
Market value$21.46M
14.96%
Sole
4.69M
Shared
0.00
None
0.00
TANGO THERAPEUTICS INC
SOLEShares390.95K
TypeSH
Market value$12.22M
8.52%
Sole
390.95K
Shared
0.00
None
0.00
SUTRO BIOPHARMA INC
SOLEShares270.25K
TypeSH
Market value$8.97M
6.25%
Sole
270.25K
Shared
0.00
None
0.00
ARRIVENT BIOPHARMA INC
SOLEShares218.69K
TypeSH
Market value$7.60M
5.29%
Sole
218.69K
Shared
0.00
None
0.00
4D MOLECULAR THERAPEUTICS INC
SOLEShares507.80K
TypeSH
Market value$6.75M
4.71%
Sole
507.80K
Shared
0.00
None
0.00
BRIGHT MINDS BIOSCIENCES INC
SOLEShares92.75K
TypeSH
Market value$6.51M
4.54%
Sole
92.75K
Shared
0.00
None
0.00
OCULAR THERAPEUTIX INC
SOLEShares532.48K
TypeSH
Market value$5.23M
3.64%
Sole
532.48K
Shared
0.00
None
0.00
ERASCA INC
SOLEShares265.20K
TypeSH
Market value$4.86M
3.39%
Sole
265.20K
Shared
0.00
None
0.00
SURROZEN INC
SOLEShares173.40K
TypeSH
Market value$4.50M
3.14%
Sole
173.40K
Shared
0.00
None
0.00
ARGEN SE - ADR
SOLEShares4.71K
TypeSH
Market value$4.37M
3.04%
Sole
4.71K
Shared
0.00
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
SOLEShares215.65K
TypeSH
Market value$4.20M
2.93%
Sole
215.65K
Shared
0.00
None
0.00
DESIGN THERAPEUTICS INC
SOLEShares282.56K
TypeSH
Market value$4.09M
2.85%
Sole
282.56K
Shared
0.00
None
0.00
MINERVA NEUROSCIENCES
SOLEShares709.50K
TypeSH
Market value$3.94M
2.74%
Sole
709.50K
Shared
0.00
None
0.00
TAYSHA GENE THERAPIES INC
SOLEShares561.81K
TypeSH
Market value$3.83M
2.67%
Sole
561.81K
Shared
0.00
None
0.00
AVALYN PHARMA INC
SOLEShares115K
TypeSH
Market value$3.79M
2.64%
Sole
115K
Shared
0.00
None
0.00
AVALO THERAPEUTICS INC
SOLEShares186.31K
TypeSH
Market value$3.44M
2.40%
Sole
186.31K
Shared
0.00
None
0.00
AMYLYX PHARMACEUTICALS INC
SOLEShares168.12K
TypeSH
Market value$3.02M
2.10%
Sole
168.12K
Shared
0.00
None
0.00
ARTIVA BIOTHERAPEUTICS INC
SOLEShares260.42K
TypeSH
Market value$2.53M
1.76%
Sole
260.42K
Shared
0.00
None
0.00
COMPASS THERAPEUTICS INC
SOLEShares595.21K
TypeSH
Market value$1.30M
0.91%
Sole
595.21K
Shared
0.00
None
0.00
UNITED THERAPEUTICS CORP
SOLEShares2.22K
TypeSH
Market value$1.21M
0.84%
Sole
2.22K
Shared
0.00
None
0.00
CONTINEUM THERAPEUTICS INC-A
SOLEShares63.09K
TypeSH
Market value$1.03M
0.72%
Sole
63.09K
Shared
0.00
None
0.00
LB PHARMACEUTICALS INC
SOLEShares28.92K
TypeSH
Market value$938.6K
0.65%
Sole
28.92K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
PRAXIS PRECISION MEDICINES ISOLE | COM NEW | 82.80K | SH | $27.72M 19.32% | 82.80K | 0.00 | 0.00 |
WHITEHAWK THERAPEUTICS INCSOLE | COM | 4.69M | SH | $21.46M 14.96% | 4.69M | 0.00 | 0.00 |
TANGO THERAPEUTICS INCSOLE | COM | 390.95K | SH | $12.22M 8.52% | 390.95K | 0.00 | 0.00 |
SUTRO BIOPHARMA INCSOLE | COM | 270.25K | SH | $8.97M 6.25% | 270.25K | 0.00 | 0.00 |
ARRIVENT BIOPHARMA INCSOLE | COM | 218.69K | SH | $7.60M 5.29% | 218.69K | 0.00 | 0.00 |
4D MOLECULAR THERAPEUTICS INCSOLE | COM | 507.80K | SH | $6.75M 4.71% | 507.80K | 0.00 | 0.00 |
BRIGHT MINDS BIOSCIENCES INCSOLE | COM NEW | 92.75K | SH | $6.51M 4.54% | 92.75K | 0.00 | 0.00 |
OCULAR THERAPEUTIX INCSOLE | COM | 532.48K | SH | $5.23M 3.64% | 532.48K | 0.00 | 0.00 |
ERASCA INCSOLE | COM | 265.20K | SH | $4.86M 3.39% | 265.20K | 0.00 | 0.00 |
SURROZEN INCSOLE | COM NEW | 173.40K | SH | $4.50M 3.14% | 173.40K | 0.00 | 0.00 |
ARGEN SE - ADRSOLE | SPONSORED ADR | 4.71K | SH | $4.37M 3.04% | 4.71K | 0.00 | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSSOLE | CLASS ORD A | 215.65K | SH | $4.20M 2.93% | 215.65K | 0.00 | 0.00 |
DESIGN THERAPEUTICS INCSOLE | COM | 282.56K | SH | $4.09M 2.85% | 282.56K | 0.00 | 0.00 |
MINERVA NEUROSCIENCESSOLE | COM NEW | 709.50K | SH | $3.94M 2.74% | 709.50K | 0.00 | 0.00 |
TAYSHA GENE THERAPIES INCSOLE | COM SHS | 561.81K | SH | $3.83M 2.67% | 561.81K | 0.00 | 0.00 |
AVALYN PHARMA INCSOLE | COM SHS | 115K | SH | $3.79M 2.64% | 115K | 0.00 | 0.00 |
AVALO THERAPEUTICS INCSOLE | COM NEW | 186.31K | SH | $3.44M 2.40% | 186.31K | 0.00 | 0.00 |
AMYLYX PHARMACEUTICALS INCSOLE | COM | 168.12K | SH | $3.02M 2.10% | 168.12K | 0.00 | 0.00 |
ARTIVA BIOTHERAPEUTICS INCSOLE | COM | 260.42K | SH | $2.53M 1.76% | 260.42K | 0.00 | 0.00 |
COMPASS THERAPEUTICS INCSOLE | COM | 595.21K | SH | $1.30M 0.91% | 595.21K | 0.00 | 0.00 |
UNITED THERAPEUTICS CORPSOLE | COM | 2.22K | SH | $1.21M 0.84% | 2.22K | 0.00 | 0.00 |
CONTINEUM THERAPEUTICS INC-ASOLE | CL A | 63.09K | SH | $1.03M 0.72% | 63.09K | 0.00 | 0.00 |
LB PHARMACEUTICALS INCSOLE | COM SHS | 28.92K | SH | $938.6K 0.65% | 28.92K | 0.00 | 0.00 |